| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/28/2013 | US20130052738 Optical based delivery of exogenous molecules to cells |
| 02/28/2013 | US20130052737 Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/28/2013 | US20130052721 Method for isolating rna from a rna and dna containing sample |
| 02/28/2013 | US20130052716 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 02/28/2013 | US20130052713 Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity |
| 02/28/2013 | US20130052710 Rna including nucleoside compound, method for regulating amount of protein produced from the rna, and nucleoside compound |
| 02/28/2013 | US20130052699 Biocatalysts for ezetimibe synthesis |
| 02/28/2013 | US20130052694 Novel cellobiohydrolase enzymes |
| 02/28/2013 | US20130052693 Cellobiohydrolase variants |
| 02/28/2013 | US20130052686 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
| 02/28/2013 | US20130052685 Prevention and treatment of complement-associated eye conditions |
| 02/28/2013 | US20130052684 Method for producing useful substances by a recombinant actinomycete, streptomyces species |
| 02/28/2013 | US20130052683 Production of galactosylated n-glycans in plants |
| 02/28/2013 | US20130052679 L-threonine analysis method and l-threonine dehydrogenase |
| 02/28/2013 | US20130052651 Methods for sequencing polynucleotides |
| 02/28/2013 | US20130052646 Positive and negative selectable markers for use in thermophilic organisms |
| 02/28/2013 | US20130052643 Method for generating nuclear reprogrammed cell, and use thereof |
| 02/28/2013 | US20130052634 Hcv genotype 4 replicons |
| 02/28/2013 | US20130052633 Hcv genotype 3 replicons |
| 02/28/2013 | US20130052329 Tomato variety nun 0030 me |
| 02/28/2013 | US20130052267 Methods of Inducing Tissue Regeneration |
| 02/28/2013 | US20130052250 Compounds and methods for biofilm disruption and prevention |
| 02/28/2013 | US20130052238 Gene delivery of oct4 and sirt1 and pharmaceutical compositions thereof |
| 02/28/2013 | US20130052230 Salmonella vaccine |
| 02/28/2013 | US20130052227 Hyperblebbing shigella strains |
| 02/28/2013 | US20130052226 Compositions and methods for preventing or treating a human parvovirus infection |
| 02/28/2013 | US20130052225 Infectious dna vaccines against chikungunya virus |
| 02/28/2013 | US20130052222 Influenza nucleic acid molecules and vaccines made therefrom |
| 02/28/2013 | US20130052218 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 02/28/2013 | US20130052217 Tumor vaccination involving a humoral immune response against self-proteins |
| 02/28/2013 | US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052202 HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES |
| 02/28/2013 | US20130052200 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 02/28/2013 | US20130052192 Activatable Constructs |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052187 Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions |
| 02/28/2013 | US20130052179 Arginine deiminase mutant and preparation and application thereof |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052165 Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | DE102010039018B4 Anti-La Antikörper und ihre Anwendung zum Immunotargeting Anti-La antibodies and their application to Immunotargeting |
| 02/28/2013 | DE102006021722B4 Oligonukleotidsonden, Peptide, Verfahren und Kits zur Anreicherung, Immobilisierung, zum Nachweis oder zur Detektion von Erwinia amylovora Oligonucleotide probes, peptides, methods and kits for the enrichment, immobilization, detection, or for detection of Erwinia amylovora |
| 02/28/2013 | CA2846572A1 Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid |
| 02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | CA2846015A1 Conditionally replicating adenovirus |
| 02/28/2013 | CA2845810A1 Anti-ox40 antibodies and methods of using the same |
| 02/28/2013 | CA2845682A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
| 02/28/2013 | CA2845681A1 Microorganisms and methods for producing 2,4-pentadienoate, butadiene, propylene, 1,3-butanediol and related alcohols |
| 02/28/2013 | CA2845579A1 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris |
| 02/28/2013 | CA2845568A1 Gene signatures for lung cancer prognosis and therapy selection |
| 02/28/2013 | CA2844913A1 Integrated method for high-throughput identification of novel pesticidal compositions and uses therefor |
| 02/27/2013 | EP2562266A1 Predetermined site luminescence measuring method, predetermined site luminescence measuring apparatus, expression amount measuring method, and measuring apparatus |
| 02/27/2013 | EP2562261A1 An improved mutagenesis method using polyethylene glycol mediated introduction of mutagenic nucleobases into plant protoplasts |
| 02/27/2013 | EP2562260A1 Soybeen seed and oil compositions and methods of making same |
| 02/27/2013 | EP2562259A2 Transgenic plants with enhanced agronomic traits |
| 02/27/2013 | EP2562258A1 Plasmid vector, method for detecting gene promoter activity, and assay kit |
| 02/27/2013 | EP2562257A1 Method for stabilizing functional nucleic acids |
| 02/27/2013 | EP2562256A2 C5a binding nucleic acids |
| 02/27/2013 | EP2562255A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof |
| 02/27/2013 | EP2562254A1 Novel dna methylation analysis method |
| 02/27/2013 | EP2562252A1 Novel restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity |
| 02/27/2013 | EP2562247A2 Pcr device including two heating blocks |
| 02/27/2013 | EP2562188A2 Compositions and methods for diagnosing and treating cancer |
| 02/27/2013 | EP2561750A1 AHAS mutants |
| 02/27/2013 | EP2561749A1 AHAS mutants |
| 02/27/2013 | EP2561364A2 Method and apparatus for forming of an automated sampling device for the detection of salmonella enterica utilizing an electrochemical aptamer biosensor |
| 02/27/2013 | EP2561101A2 X-str multiplex system |
| 02/27/2013 | EP2561089A2 Method of determining the metastatic potential of a tumor |
| 02/27/2013 | EP2561085A1 Cell-based production of nonulosonates |
| 02/27/2013 | EP2561082A1 Fumarylacetoacetate hydrolase (fah)-deficient pigs and uses thereof |
| 02/27/2013 | EP2561081A1 Reverse genetics of negative-strand rna viruses in yeast |
| 02/27/2013 | EP2561080A1 A new kanamycin compound, kanamycin-producing streptomyces species bacterium, and method of producing kanamycin |
| 02/27/2013 | EP2561079A1 Lipid binding nucleic acids |
| 02/27/2013 | EP2561078A2 NOVEL STRUCTURALLY DESIGNED shRNAs |
| 02/27/2013 | EP2561077A1 ORGANIC COMPOSITIONS TO TREAT BETA-ENaC-RELATED DISEASES |
| 02/27/2013 | EP2561076A1 Modulating xrn1 |
| 02/27/2013 | EP2561075A2 Aav-based treatment of cholesterol-related disorders |
| 02/27/2013 | EP2561074A1 Enhanced methods for gene regulation in plants |
| 02/27/2013 | EP2561073A1 Cns targeting aav vectors and methods of use thereof |
| 02/27/2013 | EP2560987A1 Biocatalytic oxidation process with alkl gene product |
| 02/27/2013 | EP2560983A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 02/27/2013 | EP2560687A2 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| 02/27/2013 | EP2560680A2 Chimpanzee adenoviral vector-based filovirus vaccines |
| 02/27/2013 | EP2560672A1 Rtef-1 variants and uses thereof |
| 02/27/2013 | EP2560479A2 Transgenic algae with enhanced oil expression |
| 02/27/2013 | EP2560478A1 Combinations including cry3aa and cry6aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | EP2560477A1 Combinations including cry34ab/35ab and cry6aaproteins to prevent development of resistance in corn rootworms(diabrotica spp.) |
| 02/27/2013 | EP2560476A1 Combinations including cry34ab/35ab and cry3ba proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | EP2560475A1 Combinations including cry34ab/35ab and cry3aa proteins to prevent development of resistance in corn rootworms (diabrotica spp.) |
| 02/27/2013 | EP2560473A1 Gene switch compositions and methods of use |
| 02/27/2013 | EP2540745A9 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 02/27/2013 | EP2093286B1 Multi-chain eukaryotic display vectors and uses thereof |
| 02/27/2013 | CN102947453A A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
| 02/27/2013 | CN102947452A Methods and compositions using listeria for adjuvant treatment of cancer |
| 02/27/2013 | CN102947451A Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
| 02/27/2013 | CN102947450A Rna preparations comprising purified modified rna for reprogramming cells |
| 02/27/2013 | CN102947449A Method for simultaneous achievement of bacteriolysis of acid-fast bacterium and separation of nucleic acid from the bacterium |
| 02/27/2013 | CN102947448A Composition for preventing evaporation of reaction solution during nucleic acid amplification reaction |